Stage and screen actor Robert Lindsay, 76, is the 100,000th signature to the petition calling for prostate cancer screening ...

Are you feeling unusually tired at the workplace or even while resting at home? Are children becoming irritable and crying without any clear reason? Many may dismiss these signs as simple exhaustion.

A 91-year-old man with a history of bladder carcinoma and left total knee arthroplasty was evaluated because of left knee pain. A culture of synovial fluid showed no growth. A diagnosis was made.

Background Congenital anomalies are among the common health problems faced by children in low- and middle-income countries, ...

The AAR held that Dry Citrate Powder used in haemodialysis is not an instrument or apparatus under Chapter 90. It was classified under HSN 29181590 as an organic chemical, attracting 18% ...

Share and Cite: Cisse, A. , Dieme, M. , Gassama, O. , Samb, M. and Diouf, A. (2026) Primary Hyperparathyroidism and Pregnancy about a Case: Association at Risk for the Mother and Fetus. Open Journal ...

Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced positive results from the Phase 3 EV-304 clinical trial (also known as ...

Dr. Raza Bokhari, Exec Chairman & CEO, Interviewed by Bloomberg Open Interest Anchor Matt Miller PHILADELPHIA, PA / ...

If approved, Dupixent would be the first targeted medicine in the EU indicated for children aged 2 to 11 years with CSU inadequately controlled ...

Approval in adults and children aged 6 years and older supported by Phase 3 trial demonstrating Dupixent significantly reduced nasal signs and symptoms, and systemic corticosteroid use or surgery comp ...

If approved, Dupixent would be the first targeted medicine in the EU indicated for children aged 2 to 11 years with CSU inadequately controlled by standard-of-care antihistamine treatment CSU is a chr ...

War, political upheaval and extreme weather defined 2025, alongside rare moments of resilience and global attention. This is 2025. In a multiformat collaboration with compelling visuals, AP ...